These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9811319)

  • 1. Re: In search of the perfect SERM: beyond tamoxifen and raloxifene.
    Williams GM
    J Natl Cancer Inst; 1998 Nov; 90(21):1671. PubMed ID: 9811319
    [No Abstract]   [Full Text] [Related]  

  • 2. In search of the perfect SERM: beyond tamoxifen and raloxifene.
    McNeil C
    J Natl Cancer Inst; 1998 Jul; 90(13):956-7. PubMed ID: 9665139
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.
    Robertson JF
    Cancer Treat Rev; 2004 Dec; 30(8):695-706. PubMed ID: 15541579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigators involved in toremifene studies call it a potentially safer antiestrogen.
    Oncology (Williston Park); 1998 Mar; 12(3):469. PubMed ID: 9534197
    [No Abstract]   [Full Text] [Related]  

  • 5. Next generation of SERMs being seen in clinic.
    Smigel K
    J Natl Cancer Inst; 1997 Jul; 89(13):913. PubMed ID: 9214669
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective estrogen receptor modulators (SERMs) in the practice].
    Nagykálnai T
    Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ; Craig Jordan V
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for the ideal SERM.
    Poletti A
    Pharmacol Res; 1999 May; 39(5):333. PubMed ID: 10328989
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I2 production by rat liver cells.
    Levine L
    BMC Cancer; 2004 Aug; 4():49. PubMed ID: 15310397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer.
    al-Alwan NA; al-Kubaisy W; al-Rawaq K
    East Mediterr Health J; 2000; 6(2-3):475-82. PubMed ID: 11556039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.
    Koda M; Jarzabek K; Haczynski J; Knapp P; Sulkowski S; Wolczynski S
    Oncol Rep; 2004 Sep; 12(3):517-21. PubMed ID: 15289830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raloxifene: a selective modulator of estrogen receptors].
    van den Brûle FA; Kalbus MF; Gaspard UJ
    J Gynecol Obstet Biol Reprod (Paris); 1999 Dec; 28(8):788-99. PubMed ID: 10635481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tales from a targeted therapy.
    Elledge RM
    J Clin Oncol; 2006 Mar; 24(9):1323-5. PubMed ID: 16505410
    [No Abstract]   [Full Text] [Related]  

  • 15. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
    Johnston SR
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of SERM and SAS (tibolone) on breast tissue].
    Gompel A; Jacob D; de Chambine S; Mimoun M; Decroix Y; Rostene W; Poitout P
    Contracept Fertil Sex; 1999 May; 27(5):368-75. PubMed ID: 10401183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogens, antiandrogens.
    Borvendég J; Hermann I; Csuka O
    Acta Physiol Hung; 1996; 84(4):405-6. PubMed ID: 9328614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiestrogens: mechanism of action and clinical applications].
    Barrón-González A; Arias-Martínez J; Castro-Romero I
    Salud Publica Mex; 2001; 43(6):577-84. PubMed ID: 11816234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
    Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
    Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health.
    Goldstein SR
    Int J Fertil Womens Med; 1999; 44(5):221-6. PubMed ID: 10569450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.